$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 17, 2025)
$4.53B
Market Cap
17.29
P/E Ratio
1.55
EPS
$27.73
52 Week High
$13.40
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
ACADIA Pharmaceuticals Inc., based in San Diego, California, is a prominent biopharmaceutical company specializing in the development and commercialization of innovative therapies targeting central nervous system disorders. The company has a robust pipeline of small molecule drugs with a significant focus on addressing unmet medical needs in conditions such as Parkinson's disease psychosis and schizophrenia. ACADIA’s commitment to scientific innovation, coupled with strategic partnerships, strengthens its competitive position in the healthcare sector and underscores its mission to enhance patient outcomes while driving sustainable growth.
LPTX
NVDA
IRBT
TSLA
CGC
WOK
PLUG
AVGO
WBD
ASST
RXRX
RZLV
PFE
F
AAL
PLTD
SNAP
INTC
ADAP
BITF
NFLX
PLTR
SOFI
ORCL
LAZR
CIFR
MARA
WULF
GOOGL
DNN
BYND
ADTX
GRAB
PCSA
T
KVUE
HOOD
MU
RIG
IVP
BAC
RGTI
IREN
VHAI
AMD
HPE
TLRY
ITUB
BTBT
QBTS
APLD
CPNG
VICI
UBER
CMG
GOOG
CLSK
NIO
AG
VALE
SMCI
PBR
HBAN
RKLB
AMC
MSFT
QS
PCG
LPTX
NVDA
IRBT
TSLA
CGC
WOK
PLUG
AVGO
WBD
ASST
RXRX
RZLV
PFE
F
AAL
PLTD
SNAP
INTC
ADAP
BITF
NFLX
PLTR
SOFI
ORCL
LAZR
CIFR
MARA
WULF
GOOGL
DNN
BYND
ADTX
GRAB
PCSA
T
KVUE
HOOD
MU
RIG
IVP
BAC
RGTI
IREN
VHAI
AMD
HPE
TLRY
ITUB
BTBT
QBTS
APLD
CPNG
VICI
UBER
CMG
GOOG
CLSK
NIO
AG
VALE
SMCI
PBR
HBAN
RKLB
AMC
MSFT
QS
PCG